Rochlin Kate

SEC source: 0001898521-26-000004 · form4-05122026_040516.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2036-05-09

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001898521-26-000002 · form4-02062026_040217.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-02-04

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001898521-25-000003 · form4-12232025_061210.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,085

F1 · balance_after: Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 4

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2025-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 6

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2028-12-13

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 5

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2028-12-13

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 12,295 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 3

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2025-05-02

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 2

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2025-10-04

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · price: The reported securities are included within 12,295 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-003344 · form4-02072025_040206.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,950

Underlying: Common Stock · 338,950 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-24-030057 · form4-12232024_041205.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,839

Underlying: Common Stock · 302,839 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 4

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,316

Underlying: Common Stock · 25,316 shares

Expires 2027-10-04

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 3

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2025-10-04

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 2

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2025-06-13

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,874

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

SEC source: 0001415889-24-022928 · form4-09052024_040909.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2034-09-04

F1 · derivative.exercise_date: Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-24-003017 · form4-02082024_090257.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,000

Underlying: Common Stock · 186,000 shares

Expires 2034-02-07

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001209191-23-058716 · doc4.xml · derivative · entry 3

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2028-12-13

F1 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001209191-23-058716 · doc4.xml · derivative · entry 2

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2025-06-13

F1 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001209191-23-058716 · doc4.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,558

F1 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

SEC source: 0001209191-23-039508 · doc4.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,800

Underlying: Common Stock · 67,800 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001209191-23-024701 · doc4.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-04-14

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001209191-22-054512 · doc4.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,555

Underlying: Common Stock · 60,555 shares

Expires 2032-10-21

F1 · derivative.exercise_date: The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001209191-22-046613 · doc4.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,263

SEC source: 0001209191-22-010790 · doc4.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,000

Underlying: Common Stock · 96,000 shares

Expires 2032-02-15

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.